New Treatment Approved in Canada for Gastrointestinal Stromal Tumor
source: pixabay.com

New Treatment Approved in Canada for Gastrointestinal Stromal Tumor

According to a story from Biotech 365, the biopharmaceutical company Deciphera Pharmaceuticals has recently announced that the company's drug ripretinib (marketed as QINLOCK™) has been approved by Health Canada. The…

Continue Reading New Treatment Approved in Canada for Gastrointestinal Stromal Tumor
New Investigative Therapy for Acute Myeloid Leukemia and Myelodysplastic Syndromes is Being Investigated
source: pixabay.com

New Investigative Therapy for Acute Myeloid Leukemia and Myelodysplastic Syndromes is Being Investigated

Antigen-specific T-cell therapy is an innovative treatment option which uses immune cells to combat cancer cells. AdventHealth is the very first in the world to use this treatment for patients…

Continue Reading New Investigative Therapy for Acute Myeloid Leukemia and Myelodysplastic Syndromes is Being Investigated
CDC Hosts Webinar on the Struggles of Those with Chronic Diseases During COVID-19 crisis
source: pixabay.com

CDC Hosts Webinar on the Struggles of Those with Chronic Diseases During COVID-19 crisis

  During this time of COVID-19, many people have some general information about COvID-19 including the knowledge that individuals over 65 years of age are at higher risk of contracting…

Continue Reading CDC Hosts Webinar on the Struggles of Those with Chronic Diseases During COVID-19 crisis

Regeneron Pharmaceuticals is Racing to Have an Antibody “Cocktail” Against COVID-19

Regeneron Pharmaceuticals recently announced that it is testing a medicine for the treatment and/or prevention of Covid-19. According to an article by CNN, the testing of its anti-SARS-CoV-2 antibody combination…

Continue Reading Regeneron Pharmaceuticals is Racing to Have an Antibody “Cocktail” Against COVID-19

Regeneron Pharmaceuticals is Racing to Have an Antibody “Cocktail” Against COVID-19

Regeneron Pharmaceuticals recently announced that it is testing a medicine for the treatment and/or prevention of Covid-19. According to an article by CNN, the testing of its anti-SARS-CoV-2 antibody combination…

Continue Reading Regeneron Pharmaceuticals is Racing to Have an Antibody “Cocktail” Against COVID-19

A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients

Parkinson's News Today recently published an article featuring a study in Italy showing the benefits of deep brain stimulation in patients with late-stage Parkinson’s disease. The history of the subthalamic…

Continue Reading A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients
Bevacizumab is Surprisingly Effective for Treating HHT
https://pixabay.com/en/laboratory-analysis-blood-2356180/

Bevacizumab is Surprisingly Effective for Treating HHT

This year, thanks to COVID-19, the European Hematology Association (EHA) took their annual conference online - but that didn't prevent some intriguing new insights and ideas. In a press release,…

Continue Reading Bevacizumab is Surprisingly Effective for Treating HHT

Three U.S. Drug Candidates are Vying for First Position By Being Tested Against COVID-19

According to a recent article in Fiercepharma, vaccines based on new technology are being developed by AstraZeneca, Moderna, and Johnson & Johnson. The trials will be funded and conducted by…

Continue Reading Three U.S. Drug Candidates are Vying for First Position By Being Tested Against COVID-19

Obstructive Sleep Apnea and ROHHAD: Are They Connected?

by Danielle Bradshaw, In the Cloud Copy A common occurrence among children that have rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation or ROHHAD syndrome is that they’re also…

Continue Reading Obstructive Sleep Apnea and ROHHAD: Are They Connected?
A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function
source: pixabay.com

A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function

By Lauren Thayer from In The Cloud Copy Latent autoimmune diabetes in adults or LADA is a slow progressing form of autoimmune diabetes. Similar to type 1 diabetes, also an…

Continue Reading A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function
Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives
source: pixabay.com

Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives

Over 2018 and 2019, BioCryst Pharmaceuticals conducted two surveys to better understand the needs and expectations of hereditary angioedema (HAE) patients. Overall, they found that despite progress in HAE therapies,…

Continue Reading Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives
Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
mohamed_hassan / Pixabay

Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

According to the ASCO Post, researchers have discovered genomic characteristics of smoldering multiple myeloma that can tell one's risk of progression to multiple myeloma. Dr. Mark Bustoros and his team…

Continue Reading Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

New Marker Found to Track Disease Progression in Charcot-Marie-Tooth Disease Type 1a

A study conducted by researchers from Aix-Marseille University in France has revealed a new way to track disease progression of Charcot-Marie-Tooth disease type 1a (CMT1a)- changes to the nerves within the thigh.…

Continue Reading New Marker Found to Track Disease Progression in Charcot-Marie-Tooth Disease Type 1a
$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders
QuinceMedia / Pixabay

$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders

Every day, the world becomes increasingly technological. With this comes advances in many realms, from healthcare to education. Recently, says Parkinson's News, medical technology company Manus Neurodynamica received £750,000 (approx. $950,000)…

Continue Reading $950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders

Positive Results Announced for a Phase 1 Trial Targeting Root of Chronic Urticarias

Celldex has just released positive results from a Phase 1 trial of an investigative therapy which could benefit patients living with chronic urticarias. This disease can result in decreased energy,…

Continue Reading Positive Results Announced for a Phase 1 Trial Targeting Root of Chronic Urticarias

Scientists Are Using a New Approach to Slow Parkinson’s Progression Through Two Compounds

A study led by Yoon Ho Sup, a Professor at NTU Singapore, and Kwang-Soo Kim, a professor at Harvard University, has uncovered two compounds with the ability to increase the…

Continue Reading Scientists Are Using a New Approach to Slow Parkinson’s Progression Through Two Compounds

US Veterans with Pulmonary Hypertension Are Not Treated with Exercise Rehabilitation

According to Healio, US veterans affected by pulmonary arterial hypertension are typically not treated with exercise rehabilitation, despite the fact that many medical professionals believe that utilizing exercise rehabilitation in…

Continue Reading US Veterans with Pulmonary Hypertension Are Not Treated with Exercise Rehabilitation
Close Menu